Fundraising FoxAndera Partners — 2025 Investments
6 investments dated 2025 · listed companies and verified rows first · show all
Adcytherix is a clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) that use approved cancer drugs as payloads combined with optimized conjugation design to overcome resistance in precision oncology.
BiotechHealthtechMedical Devices
Jack Elands(Founder & CEO)inXavier Preville(Co-founder, VP & Head of Research & Preclinical Development)inJan H.M. Schellens(Chief Medical Officer)inThierry Menguy(VP & Head of CMC Operations)inJaime Arango(Chief Financial Officer)inPaul Jackson(Chief Operating Officer)in
Co-investorsaMoonRA CapitalBpifranceAngelini VenturesKurma PartnersPontifax Venture Capital+1 more
Adler Ortho designs, manufactures, and markets joint prostheses and medical devices for the orthopaedic market.
Advanced ManufacturingHardwareHealthtechMedical DevicesCormano, IT
Alveus Therapeutics develops next-generation metabolic and obesity therapies, including its lead asset ALV-100 (in Phase 2) and a preclinical amylin pipeline of peptides, oral small molecules, and novel formats aimed at sustainable weight loss with better tolerability.
BiotechHealthtechLongevityPhiladelphia, US
Raj Kannan(Executive Officer, Director)
BoardClaudio Nessi(Director)inIvan Gergel(Director)inJan Van de Bossche(Director)inGarrett Ingram(Director)Gregory Parekh(Director)
Co-investorsAvego BioScience CapitalGlobal BioAccess FundJeito CapitalKurma PartnersNew Rhein Healthcare Investors, LLCSeroba Life Sciences+2 more
Bioptimus is an AI-first biotech company developing a universal AI foundation model that connects biology across scales, from molecules and cells to tissues and whole organisms, to support biomedical research and innovation.
AI & Machine LearningBiotechDigital HealthHealthtechParis, FR
Eric Durand(Founder)inFelipe Llinares-López(Co-founder & VP of AI)inRodolphe Jenatton(Founder)inZelda Mariet(Founder)inJean-Philippe Vert(Founder)inDavid Cahané(Co-founder & General Manager)
Co-investorsCathay InnovationFELIX CAPITALFrstHeadlineHeadline Growth Management, LLCHitachi Ventures+8 more
Spiro Medical is a clinical-stage medical device company developing neuromodulation therapies for severe, uncontrolled asthma and other respiratory conditions.
BiotechHealthtechMedical DevicesBelleair Bluffs, US
Rinda Sama(Executive Officer)in
BoardBrian Mooney(Director)
Co-investorsSupernova InvestOmega Funds
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.